HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator

被引:121
作者
Felzien, LK
Woffendin, C
Hottiger, MO
Subbramanian, RA
Cohen, EA
Nabel, GJ
机构
[1] Univ Michigan, Med Ctr, Dept Internal Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Med Ctr, Dept Biol Chem, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
[3] Univ Montreal, Fac Med, Dept Microbiol & Immunol, Lab Retrovirol Humaine, Montreal, PQ H3C 3J7, Canada
关键词
D O I
10.1073/pnas.95.9.5281
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The accessory protein, Vpr, is a virion-associated protein that is required for HIV-1 replication in macrophages and regulates viral gene expression in T cells. Vpr causes arrest of cell cycle progression at G(2)/M, presumably through its effect on cyclin B1.Cdc2 activity. Here, we show that the ability of Vpr to activate HIV transcription correlates with its ability to induce G(2)/M growth arrest, and this effect is mediated by the p300 transcriptional coactivator, which promotes cooperative interactions between the Rel A subunit of NF-kappa B and cyclin B1.Cdc2. Vpr cooperates with p300, which regulates NF-kappa B and the basal transcriptional machinery, to increase HIV gene expression. Similar effects are seen in the absence of Vpr with a kinase-deficient Cdc2, and overexpression of p300 increases levels of HIV Vpr(+) replication. Taken together, these data suggest that p300, through its interactions with NF-kappa B, basal transcriptional components, and Cdks, is modulated by Vpr and regulates HIV replication, The regulation of p300 by Vpr provides a mechanism to enhance viral replication in proliferating cells after growth arrest by increasing viral transcription.
引用
收藏
页码:5281 / 5286
页数:6
相关论文
共 58 条
[1]   HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [J].
Ayyavoo, V ;
Mahboubi, A ;
Mahalingam, S ;
Ramalingam, R ;
Kudchodkar, S ;
Williams, WV ;
Green, DR ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (10) :1117-1123
[2]   DISTINCT EFFECTS IN PRIMARY MACROPHAGES AND LYMPHOCYTES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACCESSORY GENES VPR, VPU, AND NEF - MUTATIONAL ANALYSIS OF A PRIMARY HIV-1 ISOLATE [J].
BALLIET, JW ;
KOLSON, DL ;
EIGER, G ;
KIM, FM ;
MCGANN, KA ;
SRINIVASAN, A ;
COLLMAN, R .
VIROLOGY, 1994, 200 (02) :623-631
[3]   The CBP co-activator is a histone acetyltransferase [J].
Bannister, AJ ;
Kouzarides, T .
NATURE, 1996, 384 (6610) :641-643
[4]   CBP-INDUCED STIMULATION OF C-FOS ACTIVITY IS ABROGATED BY E1A [J].
BANNISTER, AJ ;
KOUZARIDES, T .
EMBO JOURNAL, 1995, 14 (19) :4758-4762
[5]  
Bannister AJ, 1995, ONCOGENE, V11, P2509
[6]   Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G(2) accumulation by a mechanism which differs from DNA damage checkpoint control [J].
Bartz, SR ;
Rogel, ME ;
Emerman, M .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2324-2331
[7]   Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha [J].
Bhattacharya, S ;
Eckner, R ;
Grossman, S ;
Oldread, E ;
Arany, Z ;
DAndrea, A ;
Livingston, DM .
NATURE, 1996, 383 (6598) :344-347
[8]   NF-KAPPA-B-MEDIATED ACTIVATION OF THE HUMAN IMMUNODEFICIENCY VIRUS ENHANCER - SITE OF TRANSCRIPTIONAL INITIATION IS INDEPENDENT OF THE TATA BOX [J].
BIELINSKA, A ;
KRASNOW, S ;
NABEL, GJ .
JOURNAL OF VIROLOGY, 1989, 63 (09) :4097-4100
[9]   THE SAME INDUCIBLE NUCLEAR PROTEINS REGULATES MITOGEN ACTIVATION OF BOTH THE INTERLEUKIN-2 RECEPTOR-ALPHA GENE AND TYPE-1 HIV [J].
BOHNLEIN, E ;
LOWENTHAL, JW ;
SIEKEVITZ, M ;
BALLARD, DW ;
FRANZA, BR ;
GREENE, WC .
CELL, 1988, 53 (05) :827-836
[10]  
COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P11